focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

Fri, 01st Dec 2023 07:41

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

According to Nationwide, the annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis.

"There has been a significant change in market expectations for the future path of bank rate in recent months which, if sustained, could provide much needed support for housing market activity," said Robert Gardner, Nationwide's chief economist.

So far on Friday morning, there have been manufacturing purchasing managers' index readings from China, Ireland and Japan. The economic calendar still has a slew of manufacturing PMI releases, including for the EU, Germany, the UK and the US.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.3% at 7,478.50

----------

Hang Seng: down 1.0% at 16,869.78

Nikkei 225: closed down 0.2% at 33,431.51

S&P/ASX 200: closed down 0.2% at 7,073.20

----------

DJIA: closed up 520.47 points, 1.5%, at 35,950.89

S&P 500: closed up 17.22 points, or 0.4%, at 4,567.80

Nasdaq Composite: closed down 32.27 points, or 0.2%, at 14,226.22

----------

EUR: up at USD1.0911 (USD1.0909)

GBP: down at USD1.2638 (USD1.2652)

USD: up at JPY148.22 (JPY147.85)

Gold: up at USD2,040.60 per ounce (USD2,038.85)

(Brent): up at USD80.61 a barrel (USD80.56)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

08:30 EST Canada labour force survey

09:30 EST Canada manufacturing PMI

10:00 CET EU manufacturing PMI

09:50 CET France manufacturing PMI

09:55 CET Germany manufacturing PMI

09:15 CET Spain manufacturing PMI

09:30 GMT UK manufacturing PMI

09:00 EST US Fed Chicago President Austan Goolsbee speaks

09:45 EST US S&P Global manufacturing PMI

10:00 EST US ISM manufacturing PMI

----------

The annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis, according to new data from Nationwide. On a seasonally adjusted basis, UK house prices rose by 0.2% in November from October, with growth slowing slightly from a 0.9% on-month rise in October. On an annual basis, prices were 2.0% lower in November, slowing from the 3.3% fall in October. The average house price, without seasonal adjustment, was GBP258,557 in November, down from GBP259,423 in October.

----------

A rise in new orders pushed China's factory sector back into growth in November, survey results from S&P Global showed. The Caixin manufacturing purchasing managers' index rose to a three-month high of 50.7 points last month from 49.5 in October. The reading above 50 points indicates growth in the sector. The Caixin PMI moved in the opposite direction from the same indicator issued by the National Bureau of Statistics on Thursday. Its manufacturing PMI reading for November was 49.4 points, still in contraction territory and slightly down from 49.5 in October. "Demand continued to grow, as the gauge for new orders remained in expansionary territory for the fourth consecutive month, hitting the highest since June," said Wang Zhe, senior economist at Caixin Insight Group. "Compared with consumer goods and intermediate goods, the supply and demand of investment goods were weaker.

----------

Manufacturing conditions in Japan continued to worsen in November, but performed better than initially indicated. The au Jibun manufacturing PMI fell to 48.3 points in November from 48.7 in October, but outperformed the flash estimate, and FXStreet-cited consensus, which were both at 48.1. Edging away from the 50 point mark separating expansion from contraction, the reading indicates an accelerated contraction in activity.

----------

A two-month decline in factory sector activity in Ireland was arrested in November, though only just barely, amid an improvement in production requirements, according to survey results released by S&P Global. Less positively, export orders declined for the third straight month. The AIB Ireland manufacturing PMI came in at 50.0 points in November, indicating neither growth nor decline. This was up from 48.2 points in October and 49.6 in September and was the second highest reading since February.

----------

BROKER RATING CHANGES

----------

UBS raises Antofagasta to 'buy' (neutral) - price target 1,700 (1,600) pence

----------

UBS raises Anglo American to 'buy' (neutral) - price target 2,500 pence

----------

Deutsche Bank cuts Pearson to 'hold' (buy) - price target 1,050 (1,100) pence

----------

COMPANIES - FTSE 100

----------

AstraZeneca has decided to discontinue the Stabilize-ckd and Dialize-Outcomes Phase III evidence trials for Lokelma, sodium zirconium cyclosilicate. The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. They are part of the Crystalize evidence programme, which researches the benefit of Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.

----------

COMPANIES - FTSE 250

----------

3i Infrastructure said it has completed the sale of its 25% stake in Attero, a waste treatment and recycling companies in the Netherlands. The sale, to Ardian, was announced back in July. 3i will receive EUR215 million for the sale, which will be used to partially repay drawings on the company's revolving credit facility. Also, 3i said it has completed a further investment of GBP30 million in Future Biogas to fund the acquisition of two anaerobic digestion plants which are currently operated by Future Biogas.

----------

OTHER COMPANIES

----------

James Halstead updated shareholders ahead of its annual general meeting Friday. It said that whilst its "major markets face strong competition", it is seeing improved output and profits which are materially ahead of the comparatives. "We are confident of achieving full year market expectations of improved bottom line results and exceeding the half year comparatives, as well as extending our track record of increased dividends," Chair Anthony Wild said. "I and the board remain positive about the medium-term prospects for the group as a whole."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.